Investor Presentaiton

9 Overseas sales grow steadily Joyce Heo was R 启明医疗 VENUSMEDTECH Shakeel Osman was appointed as SVP of sales in Europe, responsible for sales and marketing in congenital heart disease in Mar 2022 Europe David Brean was appointed as VP of sales in Europe, responsible for adult structural heart disease as well as the direct sales in Germany, France in 2021 2021 overseas revenue Sales 10.51 Latin America appointed as sales director responsible for new maker in Mar 2022 million RMB Southeast Asia Growth Rate 160.5% Overseas sales team expanded, Venus P-Valve was approved on April 8th in Europe

View entire presentation